SKI Market

Indian Indices

Sensex

85,499.23 310.63
( 0.36%)

Global Indices

Nasdaq

48,084.29 -303.78
(-0.63%)

Dow Jones

6,866.50 -50.74
(-0.73%)

Hang Seng

50,384.39 -142.53
(-0.28%)

Nikkei 225

9,931.38 -9.33
(-0.09%)

Forex

USD-INR

89.87 0.03
(0.03%)

EUR-INR

105.50 -0.18
(-0.17%)

GBP-INR

120.91 -0.28
(-0.23%)

JPY-INR

0.57 0.00
(-0.26%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Abbott India Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500488

INE358A01014

1887.4870588

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ABBOTINDIA

40.12

60533.49

EPS(TTM)

Face Value()

Div & Yield %

710.09

1.67

Back

CCL Products (India) consolidated net profit rises 36.39% in the September 2025 quarter

Nov 06,2025

Net profit of CCL Products (India) rose 36.39% to Rs 100.86 crore in the quarter ended September 2025 as against Rs 73.95 crore during the previous quarter ended September 2024. Sales rose 52.63% to Rs 1126.73 crore in the quarter ended September 2025 as against Rs 738.20 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1126.73	738.20	53
OPM %	17.50	18.57	-
PBDT	165.98	111.00	50
PBT	127.09	87.31	46
NP	100.86	73.95	36

85,499.23 310.63 ( 0.36%)

48,084.29 -303.78 (-0.63%)

6,866.50 -50.74 (-0.73%)

50,384.39 -142.53 (-0.28%)

9,931.38 -9.33 (-0.09%)

89.87 0.03 (0.03%)

105.50 -0.18 (-0.17%)

120.91 -0.28 (-0.23%)

0.57 0.00 (-0.26%)